A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice

Study Identifier
P19-287
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

Study Details

Medical Condition
  • Blood Cancer - Chronic Lymphocytic Leukemia (CLL)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    This study will evaluate effectiveness and safety in routine clinical practice in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).

    Study Locations

    Location
    Status
    Location
    Soroka University Medical Center /ID# 207897
    Beersheba, Southern District, Israel, 8443901
    Status
    Not applicable
    Location
    The Chaim Sheba Medical Center /ID# 207900
    Ramat Gan, Tel Aviv, Israel, 5265601
    Status
    Not applicable
    Location
    Tel Aviv Sourasky Medical Center /ID# 206962
    Tel Aviv, Tel Aviv, Israel, 6423906
    Status
    Not applicable
    Location
    HaEmek Medical Center /ID# 210900
    Afula, Israel, 1834111
    Status
    Not applicable
    Location
    Rambam Health Care Campus /ID# 210320
    Haifa, Israel, 3109601
    Status
    Not applicable
    Location
    Bnai Zion Medical Center /ID# 206963
    Haifa, Israel, 3339419
    Status
    Not applicable
    Showing {first} - {last} of {total} Results